
Remotely monitored “wearable” devices are helping to pave the way for evidence-based therapy and to facilitate personalized healthcare through predictive health analytics and medicine. The technologies are already having a significant impact, but they have the potential to be game-changers for cancer. However, a number of data-related hurdles need to be overcome in order to facilitate widespread adoption of remotely monitored clinical devices in cancer treatment.